Home
Conditions
Neuroectodermal Tumors

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

5,994 public trials 1,209 recruiting studies

Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Active, Not Recruiting

Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma

NCT05798507

Conditions: Astrocytoma, Glioblastoma, Glioma, +8 more
Locations: Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Active, Not Recruiting

A Phase 2 Trial of High-Dose Ascorbate in Glioblastoma Multiforme

NCT02344355

Conditions: Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +8 more
Locations: Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma

NCT03587038

Conditions: Astrocytoma, Glioblastoma, Glioma, +7 more
Locations: Stephenson Cancer Center, University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

View Trial Details

Active, Not Recruiting

Proton Radiation Therapy for Gliomas

NCT01358058

Conditions: Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +15 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases

NCT02374242

Conditions: Brain Diseases, Brain Metastases, Brain Neoplasms, +20 more
Locations: Melanoma Institute Australia Wollstonecraft, New South Wales, Australia

Princess Alexandra Hospital Woolloongabba, Queensland, Australia

Royal Adelaide Hospital Adelaide, South Australia, Australia

Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia

View Trial Details

Active, Not Recruiting

Doxycycline in Cutaneous Schwannoma (NF2)

NCT05521048

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +25 more
Locations: Massachusetts Eye and Ear Boston, Massachusetts, United States

View Trial Details

Active, Not Recruiting

Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma

NCT05089370

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: University of Colorado Hospital Aurora, Colorado, United States

View Trial Details

Active, Not Recruiting

BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

NCT05120271

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +28 more
Locations: Hoag Hospital Newport Beach Newport Beach, California, United States

Baylor Scott and White Research Institute Dallas, Texas, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

Fred Hutchinson Cancer Center - Seattle Cancer Care Alliance (SCCA) Location Seattle, Washington, United States

View Trial Details

Active, Not Recruiting

PET Imaging of Solid Tumors Using 124I-Humanized 3F8: A Pilot Study

NCT02307630

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +16 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Phase I/IIa Study of Concomitant Radiotherapy With Olaparib and Temozolomide in Unresectable High Grade Gliomas Patients

NCT03212742

Conditions: Glioma, Malignant Gliomas, Neoplasms, +8 more
Locations: CHU Amiens, France

Institut de Cancérologie de l'Ouest Angers, France

CHU Bordeaux, France

Centre François Baclesse Caen, France

View all 15 locations

View Trial Details

Neuroectodermal Tumors

Neuroectodermal Tumors trial results

Related conditions